Andrographolide inhibits hepatoma cells growth and affects the expression of cell cycle related proteins

Yaoxue Xuebao

Volumn 44, Issue 9, 2009, Pages 973-979

  Shen, Kai Kai ^a   Liu, Tian Yu ^a   Xu, Chong ^a   Ji, Li Li ^a,b   Wang, Zheng Tao ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai R and D Centre for Standardization of Chinese Medicines   (China)

Author keywords

Andrographolide; Cell cycle related protein; Colony formation; Hepatoma cell

Indexed keywords

ANDROGRAPHOLIDE; CELL CYCLE PROTEIN; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; FLOW CYTOMETRY; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; NITROBLUE TETRAZOLIUM TEST; PROTEIN EXPRESSION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; HUMANS; LIVER NEOPLASMS;

EID: 71049136589     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55: 74-108.
2. Colombo M. Natural history of hepatocellular carcinoma [J]. Cancer Imaging, 2005, 5: 85-88.
3. Poolsup N, Suthisisang C, Prathanturaruq S, et al. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials [J]. J Clin Pharm Ther, 2004, 29: 37-45.
4. Deng WL. Outline of current clinical and pharmacological research on Andrographis paniculata in China [J]. Newsl Chin Herb Med, 1978, 10: 27-31.
5. Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy [J]. Planta Med, 2004, 70: 293-298. (Pubitemid 38594598)
6. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effects of andrographolide [J]. Int Immunopharmacol, 2009, 9: 313-318.
7. Wu CM, Cao JL, Zheng MH, et al. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics [J]. J Int Med Res, 2008, 36: 178-186.
8. Carretta MD, Alarcon P, Jara E, et al. Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation [J]. Eur J Pharmacol, 2009, 602: 413-421.
9. Basak A, Cooper S, Roberqe AG et al. Inhibition of proprotein convertases-1,-7 and furin by diterpines of Andrographis paniculata and their succinoyl esters [J]. Biochem J, 1999, 338: 107-113. (Pubitemid 29097292)
10. Shi MD, Lin HH, Lee YC, et al. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide [J]. Chem Biol Interact, 2008, 174: 201-210.
11. Li YD, Ye BQ, Zheng SX, et al. NF-kappa B transcription factor p50 critically regulates tissue factor in deep vein thrombosis [J]. J Biol Chem, 2009, 284: 4473-4483.
12. Trivedi NP, Rawal UM, Patel BP. Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury [J]. Integr Cancer Ther, 2007, 6: 271-280. (Pubitemid 47301120)
13. Manikam ST, Stanslas J. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis [J]. J Pharm Pharmacol, 2009, 61: 69-78.
14. Kim TG, Hwi KK, Hunq CS. Morphological and biochemical changes of andrographolide-induced cell death in human prostatic adenocarcinoma PC-3 cells [J]. In Vivo, 2005, 19: 551-557.
15. Satyanarayana C, Deevi DS, Rajagopalan R, et al. DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells [J]. BMC Cancer, 2004, 4:26-33. (Pubitemid 40180306)
16. Norbury C, Nurse P. Animal cell cycles and their control [J]. Annu Rev Biochem, 1992, 61: 441-470.
17. MacLachian TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer [J]. Crit Rev Eukaryot Gene Expr, 1995, 5: 127-156.
18. Spataro V. Recent advances in the molecular genetics of cancer [J]. Ann Oncol, 1998, 9: 23-29. (Pubitemid 28125760)
19. Chiu LC, Wan JM. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression [J]. Cancer Lett, 1999, 145: 17-27.
20. Chan FL, Choi HL, Chen ZY, et al. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin [J]. Cancer Lett, 2000, 160: 219-228. (Pubitemid 30798060)
21. Jo KJ, Cha MR, Lee MR, et al. Methanolic extracts of Uncaria rhynchophylla induce cytotoxicity and apoptosis in HT-29 human colon carcinoma cells [J]. Plant Foods Hum Nutr, 2008, 63: 77-82.
22. Yu WP, Jia L, Wang P, et al. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms [J]. Mol Nutr Food Res, 2008, 52: 447-456.
23. Sancar A, Lindsev-Boltz LA, Unsal-Kacmaz K, et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints [J]. Annu Rev Biochem, 2004, 73: 39-85. (Pubitemid 39050363)
24. Iruretaqovena MI, Sepulveda SE, Lezana JP, et al. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis [J]. J Pharmacol Exp Ther, 2006, 318: 59-67.
25. Bao Z, Guan S, Chenq C, et al. A novel anti-inflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway [J]. Am J Respir Crit Care Med, 2009, 179: 657-665.